Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Cervical Cancer: Contemporary Management
K Chitrathara, Shalini Rajaram, Amita Maheshwari
SECTION 1: CONVENTIONAL SCREENING, NEWER SCREENING METHODS, HPV CARCINOGENESIS, BIOMARKERS AND HPV VACCINATION
CHAPTER 1:
Cervical Cancer Screening in the Developing World
BURDEN OF CERVICAL CANCER
NATURAL HISTORY AND CONTROL OPTIONS
SCREENING TESTS AND PROGRAMS FOR CERVICAL NEOPLASIA
NEW PARADIGMS IN CERVICAL SCREENING
ACCURACY OF CERVICAL SCREENING TESTS
Cytology
Visual Screening with Acetic Acid (VIA)
Visual Inspection with Lugol's Iodine (VILI)
HPV Testing
ROUTINE SCREENING PROGRAMS IN DEVELOPING COUNTRIES
EVIDENCE FOR INCIDENCE AND MORTALITY REDUCTION FOLLOWING NONCYTOLOGY SCREENING TESTS IN DEVELOPING COUNTRIES
EFFICACY, SAFETY AND ACCEPTABILITY OF FIELD BASED TREATMENTS FOR CIN IN DEVELOPING COUNTRIES
COST-EFFECTIVE SCREENING APPROACHES IN LOW-RESOURCE SETTINGS
CLINICAL EARLY DIAGNOSIS
CONCLUSION
CHAPTER 2:
Cytology for Screening: Scope and Limitationsd
INTRODUCTION
CERVICAL CYTOLOGY AS AN EFFECTIVE SCREENING TEST
NEW CYTOLOGICAL TERMINOLOGY
THE 2001 BETHESDA SYSTEM FOR REPORTING PAP SMEAR RESULTS (ABRIDGED)
Specimen Adequacy
General Categorization (Optional)
Interpretation/Result
Negative for Intraepithelial Lesion or Malignancy
Epithelial Cell Abnormalities
Squamous cell
Glandular Cell
CURRENT PROTOCOLS FOR MANAGEMENT OF SCREEN POSITIVE
LIMITATIONS OF CERVICAL CANCER SCREENING IN DEVELOPING COUNTRIES
Regular Supply of Logistics
Establishment of Linkages to a Reliable Cytology Laboratory
Establishing Information Systems for Timely Communication of Test Results
Necessity of Multiple Visits
Requires Functional and Effective Referral Systems for Diagnosis and Treatment
Deciding on the Appropriate Age for Screening
Moderate to Low Sensitivity of Cytology Screening
Screening at Regular Intervals
Reporting Delays and Subsequent Loss of Follow-up
CERVICAL CYTOLOGY: NEW TECHNOLOGIES
New Technologies may Improve Test Accuracy
Use of Liquid-based Cytology Systems in Cervical Screening Programs
Automation-assisted Devices
COST-EFFECTIVENESS OF CERVICAL CYTOLOGY CANCER SCREENING
CONCLUSION
CHAPTER 3:
Management of Abnormal Pap Smears
INTRODUCTION
BASIS FOR CERVICAL SCREENING
LIQUID BASED CYTOLOGY
PATHOPHYSIOLOGY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
PREVENTION OF CERVICAL ABNORMALITIES
CLASSIFICATION OF PAP SMEAR
SCREENING PROGRAMS
EARLY DETECTION OF ABNORMAL PAP SMEAR AND CERVICAL INTRAEPITHELIAL NEOPLASIA
MANAGEMENT OF WOMEN WITH ASCUS ABNORMALITY
FEATURES OF DYSKARYOSIS ON CYTOLOGY
COLPOSCOPIC FEATURES OF CERVICAL INTRAEPITHELIAL NEOPLASIA
HISTOLOGICAL FEATURES OF CERVICAL INTRAEPITHELIAL NEOPLASIA
GLANDULAR NEOPLASIA
ABNORMAL CERVICAL CYTOLOGY DURING PREGNANCY AND MANAGEMENT
CONCLUSION
CHAPTER 4:
Liquid Based Cytology
INTRODUCTION
SCREENING TESTS FOR CERVICAL CANCER
CONVENTIONAL EXFOLIATIVE CERVICAL CYTOLOGY (PAPANICOLAOU TEST)
LIQUID BASED CYTOLOGY
CONCLUSION
CHAPTER 5:
HPV Carcinogenesis, Clinical Applications and Biomarkers in Cancer Cervix
INTRODUCTION
Low-risk HPV
High-risk HPV
Risk Factors for Acquiring HPV Infection
GENOME OF HPV
Long Control Region (LCR)
Early Region (E)
Late Region
MECHANISM OF CARCINOGENESIS BY HPV
HPV INFECTION
Establishment of Infection
Viral Multiplication
Host Cell Proliferation and Malignant Transformation
Viral Persistence
DEVELOPMENT OF PRECANCER AND CANCER
CLINICAL IMPLICATIONS OF HPV ONCOGENESIS
Role of HPV Detection in Screening and Follow-up in Cancer Cervix
Biomarkers for Cancer Cervix Detection
HPV Vaccine
CONCLUSION
CHAPTER 6:
Current Status of HPV DNA Testing
NATURAL HISTORY OF HPV INFECTION
HPV DNA TESTING
POLYMERASE CHAIN REACTION METHOD
HYBRID CAPTURE ASSAY (HC2)
PERFORMANCE OF HPV DNA TEST
HIGH NPV OF HPV TESTING
CLINICAL IMPLICATIONS
AGE OF SCREENING
KEY ISSUES IN HPV TESTING
CLINICAL UTILITY OF HPV TESTING
HPV DNA Testing as a Primary Screening Test
ADJUNCTIVE TESTING FOR HPV DNA TEST
HPV DNA TESTING IN THE TRIAGE OF EQUIVOCAL [ASCUS OR LOW-GRADE (LSIL)] CYTOLOGIC FINDINGS
HPV DNA Testing for Follow-up Post-treatment
HPV DNA Based Screening in the Developing World
CARE HPV TEST
MANAGEMENT OPTIONS OF POSITIVE HPV TEST
SELF SAMPLING FOR HPV DNA TESTING
COST EFFECTIVENESS
NEW PARADIGMS FOR SCREENING IN THE AGE OF HPV VACCINATION
CONCLUSION
CHAPTER 7:
Role of Colposcopy in Diagnosis
INTRODUCTION
COLPOSCOPY FOR PRIMARY SCREENING
COLPOSCOPY FOR DIAGNOSIS OF CIN
Indications for Colposcopy
Normal Colposcopic Findings
Types of Transformation Zone
Colposcopic Assessment of CIN
Assessment of Colposcopic Appearances
Reid's Colposcopic Index (RCI)
Colposcopic Features of Low-Grade Lesions (Fig. 7.10)
Colposcopic Features of High-Grade Lesions (Fig. 7.11)
COLPOSCOPIC ASSESSMENT OF MICROINVASION / INVASION
RECORDING OF OBSERVATIONS
Diagrammatic Presentation
ACCURACY OF COLPOSCOPY AS DIAGNOSTIC MODALITY
DISADVANTAGES OF COLPOSCOPY IN DIAGNOSIS OF CIN
‘See and Treat’ Protocol
COLPOSCOPIC DIRECTED BIOPSY
CONCLUSION
CHAPTER 8:
Treatment of Cervical Intraepithelial Neoplasia
Introduction
CRYOTHERAPY
LARGE LOOP EXCISION OF THE TRANSFORMATION ZONE (LLETZ OR LEEP)
COLD KNIFE CONE BIOPSY
HYSTERECTOMY
FOLLOW-UP AFTER TREATMENT OF CIN
MANAGEMENT OF CERVICAL INTRA-EPITHELIAL NEOPLASIA IN PREGNANCY
SINGLE VISIT APPROACH FOR THE TREATMENT OF CERVICAL INTRA- EPITHELIAL NEOPLASIA
CONCLUSION
CHAPTER 9:
HPV Vaccination in Primary Prevention of Cervical Cancer
INTRODUCTION
NATURAL HISTORY OF HPV INFECTION
IMMUNOLOGY OF HPV INFECTION
IMMUNOLOGY OF HPV VACCINATION
HPV VACCINES
EFFICACY OF HPV VACCINATION IN INDUCING IMMUNITY AND PREVENTING HPV INFECTION AND CERVICAL NEOPLASIA
CLINICAL PRACTICE GUIDELINES FOR HPV VACCINATION
SAFETY
CHALLENGES FOR HPV VACCINATION IN NATIONAL IMMUNIZATION PROGRAMS
CONCLUSION
SECTION 2: PATHOLOGY OF CERVICAL CANCER
CHAPTER 10:
Histopathology of Preinvasive Squamous Lesions and Microinvasive Squamous Cell Carcinoma
INTRODUCTION
Histology of Ectocervix
HISTOLOGY OF ENDOCERVIX
Concept of Transformation Zone
Dysplasia—Evidence of Disturbed Epithelial Maturation
Carcinoma In situ
Disadvantages of Dysplasia Nomenclature
Cervical Intraepithelial Neoplasia (CIN)—Need for New Terminology
Spectrum of CIN (1, 2 and 3) According to Extent of Histologic Abnormalities
Spectrum of CIN (low and high-grade) According to Patient Outcome
Human Papilloma Virus (HPV) and CIN —Relationship
Histologic Indicators of HPV Infection
Biomarkers of CIN
Microinvasive Carcinoma (MICA)
CONCLUSION
CHAPTER 11:
Pathology of Carcinoma Cervix
INTRODUCTION
PRECURSOR LESIONS
Cervical Intraepithelial Neoplasia (CIN)
CIN 1
Glandular Dysplasia
Morphological Features of CGIN
Common Interpretation Problems in Cervical Precancers
MICROINVASIVE SQUAMOUS CARCINOMA
SQUAMOUS CELL CARCINOMA
Definition
Macroscopy
Microscopy (Fig. 11.8)
Keratinizing
Nonkeratinizing
Basaloid
Verrucous
Warty
Papillary
Lymphoepithelioma Like
ENDOCERVICAL ADENOCARCINOMA
Minimal Deviation Adenocarcinoma (MDA)
Villoglandular Adenocarcinoma
UNCOMMON CARCINOMAS AND NEUROENDOCRINE TUMORS
Small Cell Carcinoma of the Cervix
Other Types of Malignancies
Histopathology Reporting
CONCLUSION
CHAPTER 12:
Adenocarcinoma and Other Rare Histologic Entities: Clinical Aspects
ADENOCARCINOMA
Endocervical Variant
Adenoma Malignum or Minimal Deviation Adenocarcinoma
Well Differentiated Villoglandular Papillary Variant
Endocervical Endometrioid Adenocarcinoma
Molecular Genetics
OTHER RARE CANCERS OF CERVIX
Adenosquamous Carcinoma
Anaplastic Small Cell /Neuroendocrine Carcinoma
Glassy Cell Carcinoma
Adenoid Cystic Carcinoma
Adenoid Basal Carcinoma
Clear Cell Carcinoma
Sarcoma
Sarcoma Botryoides
Verrucous Carcinoma
Melanoma
Cervical Lymphomas
Metastatic Carcinoma
CONCLUSION
SECTION 3: SURGICAL MANAGEMENT OF EARLY STAGE DISEASE
CHAPTER 13:
Surgical Anatomy of the Cervix
Introduction
Uterine Cervix—Anatomical Facts
Blood Supply of pelvis
Lymphatic Drainage
Nerves in the Pelvis
Pelvic Spaces
Ligaments
Cardinal Ligament
Uterosacral Ligaments
Rectal Pillars
Bladder Pillars
Vesicouterine Ligament
Pelvic Viscera
Pelvic Ureter
Urinary Bladder (Figs 13.1A and 13.2)
Rectum (Fig. 13.1B and 13.12)
Conclusion
CHAPTER 14:
Staging and Pretreatment Investigative Work-up
INTRODUCTION
ROUTES OF SPREAD OF CERVICAL CANCER
STAGING
LIMITATIONS OF CLINICAL STAGING
Revised Figo Staging for Carcinoma of Cervix
Staging Modalities9
Clinical Examination
Routine Investigations
Auxillary Studies13
Intravenous Pyelography (IVP)
Cystoscopy
Rectosigmoidoscopy
Barium enema
Diagnostic Imaging Modalities
Computed Tomography (CT)
Primary Tumor
Parametrial Involvement
Pelvic side wall disease
Bladder or Rectal involvement
Lymphatic Metastasis
Role of CT in Evaluating Cervical Cancer
Magnetic Resonance Imaging (MRI)
Normal Cervix and Primary Tumor
Parametrial Involvement
Bladder/rectal involvement
Lymph node involvement
Role of MRI in Evaluating Cervical Cancer
CT Versus MRI
Positron Emission Tomography (PET)
Staging of Cervical Carcinoma
Imaging lymph nodes and Distant Metastasis
Assessing Prognosis using pretreatment PET
False Negative and False Positive Pet Findings
Ultrasonography (USG)
Transvaginal Ultrasound (TVS) Guided Fine Needle Aspiration Cytology (FNAC) of the Parametrium
Lymphangiography
MR Lymphangiography
Preoperative Lymphoscintigraphy
Surgical Staging
Advantages of Surgical Staging
Arguments Against Surgical Staging
CONCLUSION
CHAPTER 15:
Sentinel Lymph Node Evaluation
INTRODUCTION
ROLE OF SENTINEL NODE BIOPSY IN CERVICAL CANCER—POTENTIAL USES AND ADVANTAGES (Table 15.1)
Early Cervical Cancer
Advanced Cervical Cancer
PITFALLS AND CHALLENGES
TECHNIQUE OF SENTINEL LYMPH NODE BIOPSY
Preoperative Lymphoscintigraphy
Intraoperative Identification of the Sentinel Node
Pathological Handling of Sentinel Lymph Nodes
STUDIES ON SENTINEL LYMPH NODE BIOPSY
CONCLUSION
CHAPTER 16:
Radical Trachelectomy
INTRODUCTION
HISTORY
STAGING OF EARLY CERVICAL CANCERS
TUMOR SPREAD
RADICAL VAGINAL TRACHELECTOMY WITH LAPAROSCOPIC LYMPHADENECTOMY
Indications for Radical Vaginal Trachelectomy
Preoperative Preparation
OPERATIVE TECHNIQUE- RADICAL VAGINAL TRACHELECTOMY
Laparoscopic Lymphadenectomy
Development of Vaginal Cuff
Identification of Ureters
Amputation of the Cervix and Vaginal Closure
Complications
Failed Trachelectomies
Patients at High-risk for Recurrence
Follow-up
Recurrences
Obstetric Outcomes
RADICAL ABDOMINAL TRACHELECTOMY
Specific Indications for Radical Abdominal Trachelectomy
OPERATIVE STEPS
Laparoscopic and Robotic Radical Trachelectomy
Imaging prior to radical trachelectomy
Sentinel node biopsy followed by trachelectomy
Which Operation is Better?
Neoadjuvant Chemotherapy followed by Radical Trachelectomy
Ultraconservative Approaches
Trachelectomy in Pregnancy
Trachelectomy in Pediatric Patients
CONCLUSION
CHAPTER 17:
Radical Hysterectomy with Pelvic Lymphadenectomy
Introduction
PATIENT SELECTION
RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY
PREOPERATIVE ASSESSMENT
Surgical Anatomy
The Paravesical Space
THE PARARECTAL SPACE
The Presacral Space
Space of Retzius
The Pelvic Autonomic Nerves9
The Pelvic Vessels
Vascular Anatomy13
LYMPHATIC DRAINAGE OF THE CERVIX
THE OPERATION
PRESERVATION OF OVARIAN FUNCTION
POSTOPERATIVE CARE
COMPLICATIONS
CONCLUSION
CHAPTER 18:
Surgical Technique of Radical Hysterectomy
RADICAL HYSTERECTOMY—Author's Modification
CONCLUSION
CHAPTER 19:
Laparoscopic Radical Nerve-sparing Hysterectomy
INTRODUCTION
ANATOMY
PATIENT POSITION AND PREPARATION
PELVIC LYMPHADENECTOMY
LAPAROSCOPIC NERVE-SPARING RADICAL HYSTERECTOMY
Vaginal Preparation
POSTERIOR AND LATERAL EXPOSURE
Recognition of Elements of the Uterine Pedicle and Hypogastric Nerve (Figs 19.4A to E)
Uterine Pedicle Division
Infundibulopelvic or Ovarian Ligament Division
Opening the Pouch of Douglas
ANTERIOR EXPOSURE
CARDINAL LIGAMENT RESECTION (Figs 19.6A to F)
Posterior Resection
Laterocervical Resection
Anterior Resection
VAGINAL DISSECTION, EXTRACTION AND CLOSURE
Clinical Results
Several Methods have been Described in the Past to Achieve a Nerve Sparing Dissection
Systematic Anatomical Dissection of Pelvic Nerves
Nerve-sparing Radical Hysterectomy (NS-RH) in Cervical Cancer
Nerve-sparing Pelvic Dissection in Deep Endometriosis
CONCLUSION
CHAPTER 20:
Radical Vaginal Hysterectomy
INTRODUCTION
INDICATIONS FOR SURGERY
SURGICAL TECHNIQUE
Extraperitoneal Lymphadenectomy
Radical Vaginal Hysterectomy
CONCLUSION
CHAPTER 21:
Complications of Radical Surgery
INTRODUCTION
FACTORS AFFECTING OUTCOME
INTRAOPERATIVE HEMORRHAGE
INTRAOPERATIVE INJURIES
INFECTIONS
POSTOPERATIVE HEMORRHAGE
FISTULA FORMATION
LYMPHOCYST
VENOUS THROMBOSIS AND PULMONARY EMBOLUS
NEUROPATHIES
RECTAL DYSFUNCTION
BLADDER DYSFUNCTION
SEXUAL DYSFUNCTION
LYMPHEDEMA
MEASURES TO DECREASE COMPLICATION RATES
CONCLUSION
SECTION 4: RADIOTHERAPY AND CHEMOTHERAPY: MANAGEMENT OF EARLY AND ADVANCED DISEASE
CHAPTER 22:
Radiation Therapy in Cancer Cervix: Principles and Techniques
EXTERNAL BEAM RADIATION THERAPY
BRACHYTHERAPY
Low Dose Rate Brachytherapy System (LDR)
High Dose Rate (HDR) Intracavitary Brachytherapy
PROGNOSTIC FACTORS IN CARCINOMA CERVIX
TREATMENT IN EARLY STAGE CERVICAL CANCER STAGE I B1, NON-BULKY STAGE IIA1
ADJUVANT RADIATION THERAPY
LOCALLY ADVANCED STAGE (FIGO STAGE IIB -IVA)
TREATMENT FOR RELAPSE
EXTERNAL RADIATION THERAPY PLANNING
Simulation
Field Arrangements for External Beam Radiation
COMPLICATIONS IN RADIATION THERAPY
LATE TOXICITIES OF RADIATION
ROLE OF MRI /PET FUSION IN RADIO-THERAPY PLANNING—DR JOSEPH EDISON
CHAPTER 23:
Concurrent Chemotherapy and Radiation for Carcinoma Cervix
INTRODUCTION
CHEMORADIATION THERAPY
Adjuvant Chemoradiation Therapy
High Risk Factors
Intermediate Risk Factors
Low Risk Patients
Treatment of Locally Advanced Cervical Cancer
Neoadjuvant Chemoradiation Treatment of Advanced Cervical Cancer
Which Chemotherapy Regimen is the most Optimal?
CONCLUSION
CHAPTER 24:
Interstitial Brachytherapy in Cancer Cervix
INTRODUCTION
Indications for Interstitial Brachytherapy in Cancer Cervix
Remote Afterloading
DOSE RATE: LDR, MDR, HDR AND PDR
Applicators
Technique of Interstitial Implantation
Radiation Dose Schedules
Results
Sequelae of Treatment
CONCLUSION
CHAPTER 25:
Chemotherapy for Cervical Cancer: An Update
INTRODUCTION
Palliative Chemotherapy
NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADIATION
NACT FOLLOWED BY SURGERY
NEOADJUVANT CHEMOTHERAPY FOR FERTILITY PRESERVING SURGERY
NACT: NEWER DRUGS
CONCURRENT CHEMORADIATION THERAPY (CCRT)
ADJUVANT CHEMOTHERAPY
RECENT DEVELOPMENTS: TARGETED THERAPIES
CONCLUSION
CHAPTER 26:
Complications of Pelvic Radiotherapy in Gynecological Malignancies
INTRODUCTION
Radiation Treatment and Dose Response Relationships
Radiation Tolerance Doses
Classification of Radiation Induced Reactions
Variables Affecting Normal Tissue Tolerance
Gastrointestinal Toxicity
Pathology
Signs and Symptoms
Diagnosis, Prevention and Management
Rectosigmoid Toxicities
Pathology
Diagnosis, Prevention and Management
Bladder Toxicity
Pathology
Diagnosis, Prevention and Management
Hematological Toxicities
Pelvic Fibrosis (Vaginal, Parametrial)
Bilateral Lower Limb Lymphedema
Osteoradionecrosis (ORN) Bilateral Femoral Head
Pelvic Insufficiency Stress Fractures (PIF's)
Lumbosacral Plexopathy
Premature Menopause
Strategies to Reduce Complications due to Pelvic Radiation Therapy
CONCLUSION
CHAPTER 27:
Postradiation Conservative Surgery
INTRODUCTION
Effect of Pelvic Radiation
Physiological Effect of Surgery on Ureter
Indications for Postradiation Modified Radical Hysterectomy (MRH)
Contraindications
Timing of Surgery
Post External Radiation Versus Post Radical Radiation
ASSESSMENT OF PELVIC OPERABILITY
Clinical
Imaging
Role of Positron Emission Tomography
URETER AND BLADDER
JUSTIFICATION OF SALVAGE CONSERVATIVE HYSTERECTOMY
THE MODIFICATIONS USED IN MODIFIED RADICAL HYSTERECTOMY (MRH)
General Principles
STEPS OF THE PROCEDURE
Post X-RT
Post RRT
Postoperative Management
COMPLICATIONS
Preoperative Complications
Postoperative Complications
SIMPLE MEASURES OF SKIN CARE IN LYMPHEDEMA LEGS
CONCLUSION
SECTION 5: MANAGEMENT OF RECURRENT AND METASTATIC DISEASE
CHAPTER 28:
Pelvic Exenteration
INTRODUCTION
Historical Aspects
Classification
INDICATIONS AND PATIENT SELECTION
Cervical Cancer
Metastatic Workup: (See the Chapter on Post– radiation Conservative Hysterectomy)
Contraindications
Preoperative Assessment and Preparation
1. Medical Evaluation
2. Counseling
3. Procedures Include Preparative Procedures
OPERATIVE PROCEDURE
Position
Anesthesia
Explorative Laparotomy
TECHNIQUE OF PELVIC EXENTERATION
Mobilization to Assess Pelvic Sidewall and Nodal Involvement
Perineal Phase
A Technique for Control of Hemorrhage
Reconstructive Phase
Urinary Diversion
Conduit Formation
Technique of Ileal Conduit
Stenting of Ureteric Anastomosis
Technique of Making Feeding Tube to Self-retaining Stent
Continent Reservoirs
Right Colon and Ileum
Sigma Rectum Pouch
Selection of Patients for Continent Diversions
Stomal Sites
Colostomy vs Low Coloanal Anastomosis
Pelvic Floor Reconstruction
Vaginal Reconstruction
POSTOPERATIVE CARE
COMPLICATIONS
Complications of Intestinal Urinary Diversion
Electrolyte Abnormalities
Altered Sensorium
Exenteration Our Experience
PELVIC EXENTERATION IN ENDOMETRIAL CANCER
PELVIC EXENTERATION IN OVARIAN CANCER
CONCLUSION
CHAPTER 29:
Role of Chemotherapy in Recurrent/Metastatic Cervical Cancer
INTRODUCTION
EVALUATION OF THE PATIENT
PROGNOSTIC FACTORS FOR PREDICTING RESPONSE TO TREATMENT
SINGLE AGENT CHEMOTHERAPY
IA. Platinum Based Singlet Therapy
I B. Nonplatinum Based Singlet Therapy
DOUBLE AGENT CHEMOTHERAPY
II A. Platinum Containing Doublets
II B. Nonplatinum Containing Doublets
III. Triplet Combination Chemotherapy
IV. Antiangiogenic Agent Plus Chemotherapy
V. Immunotherapeutic Approaches
CONCLUSION
SECTION 6: IMAGING MODALITIES FOR CANCER CERVIX
CHAPTER 30:
Role of Imaging
INTRODUCTION
ULTRASOUND
COMPUTED TOMOGRAPHY
MAGNETIC RESONANCE IMAGING
MRI Appearance of Cervical Carcinoma
MRI for Staging
MRI for Recurrence
POSITRON EMISSION TOMOGRAPHY
CONCLUSION
SECTION 7: SPECIAL CASE SCENARIOS
CHAPTER 31:
Pregnancy and Cervical Neoplasia
INTRODUCTION
DIAGNOSIS
COLPOSCOPY
CERVICAL BIOPSY
Effect of Cancer Cervix on Pregnancy and Vice Versa
MANAGEMENT
Management of Abnormal Cytology in Pregnancy19
ASC-US
ASC-H
LSIL
HSIL
AGC
Management of Premalignant lesions of Cervix20
CIN 1
CIN 2,3
Management of Microinvasive and Invasive Cancer
Stage IA1
Stage IA2, IB, IIA
Stages IIB, III and IV
Mode of Delivery
PROGNOSIS
CONCLUSION
CHAPTER 32:
Management of Invasive Carcinoma Cervix after Inadvertent Hysterectomy
INTRODUCTION
Cervical Carcinoma in Patients undergoing Simple Hysterectomy
Reasons for Simple Hysterectomy
Is Simple Hysterectomy Adequate for Invasive Cervical Cancer?
Studies Suggesting Less Radical Approach in Selected Early Stage Disease
What are the Options of Treatment after Simple Hysterectomy?
Effectiveness of Postoperative Radiation after Simple Hysterectomy
Prognostic Factors
Complications of Postoperative Radiation
CONCLUSION
SECTION 8: PALLIATIVE CARE
CHAPTER 33:
Palliative and End of Life Care for Patients with Cervical Cancer
INTRODUCTION
PHYSICAL SYMPTOMS AND THEIR MANAGEMENT
Pain
Assessment of Pain
MANAGEMENT OF PAIN
General Guidelines
STEP 1: Analgesics for Mild Pain
STEP 2: Analgesics for Moderate Pain
STEP 3: Analgesics for Severe Pain
ROUTE OF ADMINiSTRATION
Analgesics for Neuropathic Pain
Management of Neuropathic Pain
Adjuvants to Drugs in the Management of Pain
Other Common Symptoms
Bleeding
Discharge
Vesicovaginal- and Rectovaginal Fistulae
Bilateral Ureteric Obstruction
Nausea and Vomiting
MALIGNANT INTESTINAL OBSTRUCTION
CONSTIPATION
Treatment
ANOREXIA AND FATIGUE
DYSPNEA AND TERMINAL SEDATION
Management
PSYCHOLOGICAL SYMPTOMS AND THEIR MANAGEMENT
Stages of Grief
Breaking Bad News
Spiritual Care
Bereavement Support
Social and Financial Aid
Euthanasia
Where?
Home
Hospice
Training Center
CONCLUSION
INDEX
TOC
Index
×
Chapter Notes
Save
Clear